Is the FDA cracking down on poppers?
toggle caption
Poppers, a substance commonly associated with nightlife and the LGBTQ+ community, are in the spotlight following recent claims from a producer, Double Scorpio, about a potential crackdown by the FDA. The company reported halting operations due to a raid related to their products, though no official confirmation from the FDA has emerged regarding such an incident. This has sparked concern and speculation, particularly among queer communities, reminiscent of the regulatory battles of the 1980s.
Experts and commentators discuss the FDA’s ongoing scrutiny of poppers, reflecting on historical precedents and potential implications for the community. The conversation brings attention to the health policy issues surrounding these substances and how they disproportionately impact LGBTQ+ individuals.
